Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma

LESSONS LEARNED: Trials focusing on unresectable multifocal glioblastoma are needed because of the extremely poor prognosis and challenges in receiving standard therapy, such as concurrent radiation and chemotherapy. Developing a strategy to chemically debulk tumors before radiation and/or surgery i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Peters, Katherine B., Lou, Emil, Desjardins, Annick, Reardon, David A., Lipp, Eric S., Miller, Elizabeth, Herndon, James E., McSherry, Frances, Friedman, Henry S., Vredenburgh, James J.
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2015
Matèries:
Clinical Trial Results
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4492239/
https://ncbi.nlm.nih.gov/pubmed/26025933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0135
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars